NASDAQ · ACONWHealthcareMedical Labs

Aclarion, Inc. Warrant financials

$0.0256−0.39%
Close Sep 28, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
Revenue$75.7K$45.7K$75.4K$60.4K
Gross profit$6.8K-$38.9K-$324.00-$4.9K
Gross margin9.0%−85.2%−0.4%−8.0%
Operating income-$7.1M-$5.5M-$4.9M-$5.6M
Net income-$7.2M-$7.1M-$4.9M-$7.5M
Net margin−9560.7%−15424.3%−6513.4%−12381.9%
Diluted EPS$-13.61$-7478.90$-79215.71$-177372.45
EBITDA-$6.8M-$5.3M-$4.7M-$5.4M
Operating cash flow-$7.2M-$5.3M-$3.6M-$4.9M
Free cash flow-$7.2M-$5.3M-$3.6M-$4.9M
Diluted shares0.5M0.0M0.0M0.0M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31
Cash & equivalents$12.0M$453.7K$1.0M$1.5M
Short-term investments$0.00$0.00$0.00$0.00
Total debt$0.00$0.00$1.1M$0.00
Total assets$13.7M$2.1M$2.5M$2.9M
Total liabilities$837.3K$1.2M$3.2M$688.7K
Shareholders' equity$12.8M$970.1K-$728.0K$2.2M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology